Aminoacyl-tRNA synthetases in human health and disease

AK Turvey, GA Horvath, ARO Cavalcanti - Frontiers in Physiology, 2022 - frontiersin.org
The Aminoacyl-tRNA Synthetases (aaRSs) are an evolutionarily ancient family of enzymes
that catalyze the esterification reaction linking a transfer RNA (tRNA) with its cognate amino …

CD19-targeted CAR T cells in refractory antisynthetase syndrome

F Müller, S Boeltz, J Knitza, M Aigner, S Völkl… - The Lancet, 2023 - thelancet.com
Idiopathic inflammatory myopathies are a group of rare, immune-mediated diseases that
primarily affect the skeletal muscle but can also involve other organs such as the lungs, skin …

[HTML][HTML] Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies

MY Choi, M Satoh, MJ Fritzler - Current Opinion in Rheumatology, 2023 - journals.lww.com
Update on autoantibodies and related biomarkers in autoimmun... : Current Opinion in
Rheumatology Update on autoantibodies and related biomarkers in autoimmune inflammatory …

Molecular features and stages of pulmonary fibrosis driven by type 2 inflammation

H Mattoo, DS Bangari, S Cummings… - American Journal of …, 2023 - atsjournals.org
Systemic sclerosis (SSc) is a progressive, multiorgan disease with limited treatment options.
Although a recent proof-of-concept study using romilkimab or SAR156597, a bispecific IL …

[HTML][HTML] Efzofitimod: A novel anti-inflammatory agent for sarcoidosis

RP Baughman, V Niranjan, G Walker… - … Vasculitis, and Diffuse …, 2023 - ncbi.nlm.nih.gov
Efzofitimod is a first-in-class biologic immunomodulator based on a naturally occurring
splice variant of histidyl-tRNA synthetase (HARS) that binds to neuropilin-2 (NRP2) …

Mechanistic perspectives on anti-aminoacyl-tRNA synthetase syndrome

S Kanaji, W Chen, Y Morodomi, R Shapiro… - Trends in biochemical …, 2023 - cell.com
Antisynthetase syndrome (ASSD) is an autoimmune disease characterized by circulating
autoantibodies against one of eight aminoacyl-tRNA synthetases (aaRSs). Although these …

Clinical characteristics of anti-synthetase syndrome and variables associated with interstitial lung disease and mortality: a retrospective cohort study

T Sodsri, T Petnak, P Ngamjanyaporn - Journal of Clinical Medicine, 2023 - mdpi.com
Anti-synthetase syndrome (ASS) is a rare autoimmune disease. Since the knowledge of ASS
remains limited, we conducted the retrospective study aiming to describe clinical …

[PDF][PDF] Issues in the classification of myositis patients: an ongoing process

G Zanframundo, A Selva-O'Callaghan… - Clin Exp …, 2024 - clinexprheumatol.org
The authors identified different pitfalls in the criteria and suggested actions that a possible
revision should take to overa come them. The focus is surely well directed, but we believe …

Clinical Characteristics of Anti‐synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project

S Faghihi‐Kashani, A Yoshida, F Bozan… - Arthritis & …, 2024 - Wiley Online Library
Objective Anti‐synthetase syndrome (ASSD) is a rare systemic autoimmune rheumatic
disease (SARD) with significant heterogeneity and no shared classification criteria. We …

Quantification of autoantibodies using a luminescent profiling method in autoimmune interstitial lung disease

PD Burbelo, JA Huapaya, Z Khavandgar… - Frontiers in …, 2024 - frontiersin.org
Autoantibodies are important for the diagnosis of autoimmune interstitial lung disease (ILD).
Standard immunoassays have limitations, including their qualitative nature and/or a narrow …